Protagenic Therapeutics, Inc.\new Weighted Average Number of Shares Outstanding, Basic and Diluted
Protagenic Therapeutics, Inc.\new (PTIX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 14.74 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-07.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-04-07
- Protagenic Therapeutics, Inc.\new weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 17.15M shares, a 62.76% increase year-over-year.
- Protagenic Therapeutics, Inc.\new weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 16.52M shares, a 60.79% increase year-over-year.
- Protagenic Therapeutics, Inc.\new weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 14.49M shares, a 41.18% increase year-over-year.
- Protagenic Therapeutics, Inc.\new weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 10.52M shares, a 2.52% increase year-over-year.
- Protagenic Therapeutics, Inc.\new weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 14.74M shares, a 42.57% increase from fiscal 2020.
- Protagenic Therapeutics, Inc.\new weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 10.34M shares, a 0.76% increase from fiscal 2019.
- Protagenic Therapeutics, Inc.\new weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 10.26M shares, a 0.00% change from fiscal 2018.
- Protagenic Therapeutics, Inc.\new weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 10.26M shares, a 0.00% change from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | 17.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-07 | 16.83M shares derived: average of 2 quarters · filed 2022-04-07 | 16.05M shares derived: average of 3 quarters · filed 2022-04-07 | 14.74M shares 10-K · filed 2022-04-07 | |
| 2021-09-30 | 16.52M shares 10-Q · filed 2021-11-15 | 15.50M shares derived: average of 2 quarters · filed 2021-11-15 | 13.94M shares 10-Q · filed 2021-11-15 | 13.02M shares derived: average of 4 quarters · filed 2022-04-07 | |
| 2021-06-30 | 14.49M shares 10-Q · filed 2021-08-16 | 12.49M shares 10-Q · filed 2021-08-16 | 11.85M shares derived: average of 3 quarters · filed 2022-04-07 | 11.45M shares derived: average of 4 quarters · filed 2022-04-07 | |
| 2021-03-31 | 10.52M shares 10-Q · filed 2021-05-17 | 10.53M shares derived: average of 2 quarters · filed 2022-04-07 | 10.44M shares derived: average of 3 quarters · filed 2022-04-07 | 10.40M shares derived: average of 4 quarters · filed 2022-04-07 | |
| 2020-12-31 | 10.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-07 | 10.41M shares derived: average of 2 quarters · filed 2022-04-07 | 10.36M shares derived: average of 3 quarters · filed 2022-04-07 | 10.34M shares 10-K · filed 2022-04-07 | |
| 2020-09-30 | 10.28M shares 10-Q · filed 2021-11-15 | 10.27M shares derived: average of 2 quarters · filed 2021-11-15 | 10.27M shares 10-Q · filed 2021-11-15 | 10.27M shares derived: average of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | 10.26M shares 10-Q · filed 2021-08-16 | 10.26M shares 10-Q · filed 2021-08-16 | 10.26M shares derived: average of 3 quarters · filed 2021-08-16 | 10.26M shares derived: average of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | 10.26M shares 10-Q · filed 2021-05-17 | 10.26M shares derived: average of 2 quarters · filed 2021-05-17 | 10.26M shares derived: average of 3 quarters · filed 2021-05-17 | 10.26M shares derived: average of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | 10.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 10.26M shares derived: average of 2 quarters · filed 2021-03-25 | 10.26M shares derived: average of 3 quarters · filed 2021-03-25 | 10.26M shares 10-K · filed 2021-03-25 | |
| 2019-09-30 | 10.26M shares 10-Q · filed 2020-11-16 | 10.26M shares derived: average of 2 quarters · filed 2020-11-16 | 10.26M shares 10-Q · filed 2020-11-16 | 10.26M shares derived: average of 4 quarters · filed 2020-11-16 | |
| 2019-06-30 | 10.26M shares 10-Q · filed 2020-08-14 | 10.26M shares 10-Q · filed 2020-08-14 | 10.26M shares derived: average of 3 quarters · filed 2020-08-14 | 10.26M shares derived: average of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | 10.26M shares 10-Q · filed 2020-06-18 | 10.26M shares derived: average of 2 quarters · filed 2020-06-18 | 10.26M shares derived: average of 3 quarters · filed 2020-06-18 | 10.26M shares derived: average of 4 quarters · filed 2020-06-18 | |
| 2018-12-31 | 10.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29 | 10.26M shares derived: average of 2 quarters · filed 2020-04-29 | 10.26M shares derived: average of 3 quarters · filed 2020-04-29 | 10.26M shares 10-K · filed 2020-04-29 | |
| 2018-09-30 | 10.26M shares 10-Q · filed 2019-11-14 | 10.26M shares derived: average of 2 quarters · filed 2019-11-14 | 10.26M shares 10-Q · filed 2019-11-14 | 10.26M shares derived: average of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | 10.26M shares 10-Q · filed 2019-08-14 | 10.26M shares 10-Q · filed 2019-08-14 | 10.26M shares derived: average of 3 quarters · filed 2019-08-14 | 10.26M shares derived: average of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | 10.26M shares 10-Q · filed 2019-05-16 | 10.26M shares derived: average of 2 quarters · filed 2019-05-16 | 10.26M shares derived: average of 3 quarters · filed 2019-05-16 | 10.26M shares derived: average of 4 quarters · filed 2019-05-16 | |
| 2017-12-31 | 10.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | 10.26M shares derived: average of 2 quarters · filed 2019-03-29 | 10.26M shares derived: average of 3 quarters · filed 2019-03-29 | 10.26M shares 10-K · filed 2019-03-29 | |
| 2017-09-30 | 10.26M shares 10-Q · filed 2018-11-08 | 10.26M shares derived: average of 2 quarters · filed 2018-11-08 | 10.26M shares 10-Q · filed 2018-11-08 | 10.13M shares derived: average of 4 quarters · filed 2018-11-08 | |
| 2017-06-30 | 10.26M shares 10-Q · filed 2018-08-14 | 10.26M shares 10-Q · filed 2018-08-14 | 10.09M shares derived: average of 3 quarters · filed 2018-08-14 | 9.56M shares derived: average of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | 10.26M shares 10-Q · filed 2018-05-15 | 10.00M shares derived: average of 2 quarters · filed 2018-05-15 | 9.32M shares derived: average of 3 quarters · filed 2018-05-15 | 8.64M shares derived: average of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | 9.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | 8.85M shares derived: average of 2 quarters · filed 2018-04-02 | 8.11M shares derived: average of 3 quarters · filed 2018-04-02 | 5.31M shares 10-K · filed 2018-04-02 | |
| 2016-09-30 | 7.96M shares 10-Q · filed 2017-11-13 | 7.28M shares derived: average of 2 quarters · filed 2017-11-13 | 3.83M shares 10-Q · filed 2017-11-13 | 103.65M shares derived: average of 4 quarters · filed 2017-11-13 | |
| 2016-06-30 | 6.61M shares 10-Q · filed 2017-08-08 | 35.13K shares 10-Q · filed 2016-08-15 | 1.78M shares 10-Q · filed 2017-08-08 | 135.54M shares derived: average of 3 quarters · filed 2017-08-08 | 103.31M shares derived: average of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | 13.99K shares 10-Q · filed 2017-05-15 | 216.42M shares 10-Q · filed 2016-07-25 | 200.01M shares derived: average of 2 quarters · filed 2017-05-15 | 135.54M shares derived: average of 3 quarters · filed 2017-05-15 | 103.31M shares derived: average of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | 400.00M shares 10-Q · filed 2016-03-11 | 400.00M shares 10-Q · filed 2016-03-11 | 137.74M shares derived: average of 3 quarters · filed 2016-11-17 | 6.61M shares 10-K/A · filed 2017-05-08 | |
| 2015-09-30 | 6.61M shares 10-Q · filed 2016-11-17 | 400.00M shares 10-Q · filed 2015-11-13 | 6.61M shares derived: average of 2 quarters · filed 2016-11-17 | 6.61M shares 10-Q · filed 2016-11-17 | 104.96M shares derived: average of 4 quarters · filed 2016-11-17 |
| 2015-06-30 | 6.61M shares 10-Q · filed 2016-08-15 | 6.61M shares 10-Q · filed 2016-08-15 | 137.74M shares derived: average of 3 quarters · filed 2016-08-15 | 400.00M shares 10-K · filed 2015-09-25 | |
| 2015-03-31 | 6.61M shares 10-Q · filed 2016-07-25 | 203.31M shares derived: average of 2 quarters · filed 2016-07-25 | 268.87M shares derived: average of 3 quarters · filed 2016-07-25 | ||
| 2014-12-31 | 400.00M shares 10-Q · filed 2016-03-11 | 400.00M shares 10-Q · filed 2016-03-11 | 6.61M shares 8-K/A · filed 2016-07-12 | ||
| 2014-09-30 | 400.00M shares 10-Q · filed 2015-11-13 | ||||
| 2014-06-30 | 400.00M shares 10-K · filed 2015-09-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |